I declare that I am

Ask us



ASCRS 2016 has been one of the most important conventions for Medicem. We had numerous contacts from Physicians and Industry, clearly indicating that the WIOL-CF is gaining more and more visibility and consensus among the ophthalmic innovations. A particular Thank You for this achievement goes to all the investigators driving our International Clinical Trial.

WIOL-CF was presented in the congress scientific program within the Cataract & Presbyopia Session on Multifocal and Extended Depth-Of-Focus IOLs (link here to the abstract).

It is our pleasure to share with you that for this presentation Dr. Sheraz Daya won the Award for the best paper of the session and his experience with bioanalogic WIOL-CF was later reviewed within the Best of ASCRS General Session on Tuesday.